Literature DB >> 22556337

Isolated rabbit working heart function during progressive inhibition of myocardial SERCA activity.

Elspeth B Elliott1, Allen Kelly, Godfrey L Smith, Christopher M Loughrey.   

Abstract

RATIONALE: The extent to which sarcoplasmic reticulum Ca(2+)ATPase (SERCA) activity alone determines left ventricular (LV) pump function is unknown.
OBJECTIVE: To correlate SERCA activity with hemodynamic function of rabbit LV during thapsigargin perfusion. METHODS AND
RESULTS: Isolated rabbit hearts were perfused in working heart configuration, and LV pump function was assessed using a pressure-volume catheter. Rapid and complete (>95%) inhibition of SERCA was associated with a moderate decrease in cardiac function (to 70%-85% of control). Further decrease in cardiac function to 50%-75% of control occurred over the next ≈ 30 minutes despite no detectable further inhibition of SERCA activity. Analysis of the 20 seconds prior to pump failure revealed a rapid decrease in end diastolic volume. Intermediate levels of SERCA function (≈ 50% of control) had only minor hemodynamic effects. Parallel experiments in field-stimulated isolated ventricular cardiomyocytes monitored intracellular Ca(2+) and cell shortening. On perfusion with thapsigargin, Ca(2+) transient amplitude and cell shortening fell to ≈ 70% of control followed by increased diastolic Ca(2+) concentration and diastolic cell shortening to achieve a new steady state.
CONCLUSIONS: The relationship between SERCA activity and LV function in the rabbit is highly nonlinear. In the short term, only moderate effects on LV pump function were observed despite almost complete (>95%) reduction in SERCA activity. The terminal decline of function was associated with sudden sustained increase in diastolic tone comparable to the sustained contraction observed in isolated cardiomyocytes. Secondary increases of intracellular Ca(2+) and Na(+) following complete SERCA inhibition eventually limit contractile function and precipitate LV pump failure.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22556337     DOI: 10.1161/CIRCRESAHA.111.262337

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  6 in total

1.  Gene Therapy With Angiotensin-(1-9) Preserves Left Ventricular Systolic Function After Myocardial Infarction.

Authors:  Caroline Fattah; Katrin Nather; Charlotte S McCarroll; Maria P Hortigon-Vinagre; Victor Zamora; Monica Flores-Munoz; Lisa McArthur; Lorena Zentilin; Mauro Giacca; Rhian M Touyz; Godfrey L Smith; Christopher M Loughrey; Stuart A Nicklin
Journal:  J Am Coll Cardiol       Date:  2016-12-20       Impact factor: 24.094

Review 2.  The Control of Diastolic Calcium in the Heart: Basic Mechanisms and Functional Implications.

Authors:  David A Eisner; Jessica L Caldwell; Andrew W Trafford; David C Hutchings
Journal:  Circ Res       Date:  2020-01-30       Impact factor: 17.367

3.  Role of Reduced Sarco-Endoplasmic Reticulum Ca2+-ATPase Function on Sarcoplasmic Reticulum Ca2+ Alternans in the Intact Rabbit Heart.

Authors:  Lianguo Wang; Rachel C Myles; I-Ju Lee; Donald M Bers; Crystal M Ripplinger
Journal:  Front Physiol       Date:  2021-05-11       Impact factor: 4.566

4.  Prominent heart organ-level performance deficits in a genetic model of targeted severe and progressive SERCA2 deficiency.

Authors:  Frazer I Heinis; Kristin B Andersson; Geir Christensen; Joseph M Metzger
Journal:  PLoS One       Date:  2013-11-04       Impact factor: 3.240

5.  RUNX1: an emerging therapeutic target for cardiovascular disease.

Authors:  Alexandra Riddell; Martin McBride; Thomas Braun; Stuart A Nicklin; Ewan Cameron; Christopher M Loughrey; Tamara P Martin
Journal:  Cardiovasc Res       Date:  2020-07-01       Impact factor: 10.787

6.  Comparison of 10 Control hPSC Lines for Drug Screening in an Engineered Heart Tissue Format.

Authors:  Ingra Mannhardt; Umber Saleem; Diogo Mosqueira; Malte F Loos; Bärbel M Ulmer; Marc D Lemoine; Camilla Larsson; Caroline Améen; Tessa de Korte; Maria L H Vlaming; Kate Harris; Peter Clements; Chris Denning; Arne Hansen; Thomas Eschenhagen
Journal:  Stem Cell Reports       Date:  2020-10-13       Impact factor: 7.765

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.